Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Mhairi Copland, MB ChB, PhD, of Paul O’Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, UK, outlines the challenging scenarios in chronic myeloid leukemia (CML), highlighting how CML can still be a deadly disease. This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.